Endexx Corporation’s (OTC: EDXC) Subsidiary Plant-Based Vape Hyla Se-cures Two Purchase Orders For Greater Than 200,000 Units Combined Within The First Month Of Acquisition; Todd Davis, CEO Of EDXC, Says Orders ‘Ex-pedite Our Growth Initiatives’


Endexx Corporation’s (OTC: EDXC) controlling-interest subsidiary plant-based vape 4,500 system Hyla announces today it has secured two purchase orders for greater than 200,000 units combined within the first month of acquisition. Todd Davis, CEO of EDXC, says orders ‘expedite our growth initiatives’. Guarana and Levodopa based non-nicotine vaping product is seen by Company as replacing the recently banned nicotine products sold internationally where vape products are available.

StockMarketPress is  a media company which is spotlighting the cannabis industry analyzing how growth in cannabis legalization by state in 2022 could impact companies and investors. Some of the stocks it recently reported on include Endexx Corporation (OTC: EDXC), Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS) Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF), The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), OrganiGram Holdings Inc. (NASDAQ: OGI), Canopy Growth Corp. (NASDAQ: CGC) CBD Unlimited, Inc. (OTC PINK: EDXC).

Combined, these orders are for 150,000 units and 52,000 units. They occurred within the first month of the acquisition by EDXC of the Hyla vaping brand. At the same time, Hyla’s division completed the first production run on its new 4,500 puff vape system per built in cartridge unit.

Todd Davis, CEO of Endexx, says, “HYLA’s new product line fills a major gap created by the banning of flavored nicotine vape products. We believe plant-derived products are the alternative and the solution that meets market demands today. The two purchase orders came from prominent distributors in the West Coast region of the U.S. and a large western region in Asia. These orders expand both our international and domestic distribution networks helping to expedite our growth initiatives.”

The Hyla brand is an innovative vape-delivery product that holds 4,500 puffs per built in cartridge disposable unit. The Company says this expanded puff capacity ‘far exceeds’ the capacity of its competitor’s products worldwide.

Hyla develops and distributes zero-nicotine plant-powered, vape-delivered made with vegan formulations and functional plant extract ingredients. It utilizes Guarana and Levodopa plant extract ingredients.

Endexx also markets a line of all natural topical skincare, including balms, creams, lotions, butters, masks, scrubs and oil. The goal is healthy skin and grooming wellness.

Non-Nicotine Vaping is a game changer and is forecast to achieve a 27.3%+ CAGR through 2028 in a fast growth market. Endexx Corporation’s (OTC: EDXC) recently acquired Hyla brand Guarana plant Vape products have wide U.S. and international distribution. EDXC’s subsidiary Hyla is also winning online and retail shelf space in Amazon (NASDAQ: AMZN) plus more than 1,000 stores such as Target (NYSE: TGT), Walgreens (NASDAQ: WBA) and CVS (NYSE: CVS). Its goal globally to be on sale in 19 countries by the end of 2022. Research firm Grand View Research predicts a 27.3% CAGR for vaping 2021-2028.

In its recently filed Form 8-K, EDXC details the acquisition and how it has

strengthened the Company’s balance sheet in the process.

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.


Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com https://twitter.com/PressStock

Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press